BioCentury
ARTICLE | Company News

OctoPlus CEO Sturge leaving

November 5, 2010 12:26 AM UTC

Drug delivery company OctoPlus N.V. (Euronext:OCTO) said CEO Simon Sturge will depart on Jan. 1, 2011, to lead a division of an undisclosed pharmaceutical company. The company's board nominated Jan Eg...